Picking up the opening post: that is the part I would want checked first.
Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The published trials used a calendar-based schedule. Tolerability-based escalation has no formal evidence base but is not uncommon in practice.
This follows post #3 rather than contradicting it.
Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that stepping down is followed by some regain, with the magnitude unknown.
When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a reasonable response. If the side effect is not dose-dependent (e.g., hypoglycemia with insulin), dose reduction does not address the issue.
When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a reasonable response. If the side effect is not dose-dependent (e.g., hypoglycemia with insulin), dose reduction does not address the issue.
Coming back to post #27, because the follow-up matters more than the original answer.
The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower.
Read the full topic (29 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Revisiting: Holding a dose indefinitely: is there a documented downside?
The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it. A question about technique rather than…
|
+26 | 30 | 4.5k | 18mo |
|
Titrating on tolerability rather than on the calendar — the long version
Titrating on tolerability rather than on the calendar — the long version Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it, in…
|
2 | 7.7k | 17mo | |
|
Stepping down deliberately, and how to do it without losing progress — what changed since
Posting this under the heading it deserves: Stepping down deliberately, and how to do it without losing progress — what changed since Everything below is what sits behind that. Practical question with the…
|
+94 | 99 | 29k | 2d |
|
Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
|
+27 | 31 | 432 | 18mo |
|
What steady state means for the decision to escalate
What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. Reporting something rather than asking about it, in case the…
|
+31 | 35 | 2k | 1d |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Drawing from a pen cartridge with a syringe: how the risk profile changes
Posting this under the heading it deserves: Drawing from a pen cartridge with a syringe: how the risk profile changes Everything below is what sits behind that. I have read the maintained page on this and I…
|
2 | 159 | 19mo | |
|
Rewriting my first post: a before-and-after, with commentary — what changed since
Posting this under the heading it deserves: Rewriting my first post: a before-and-after, with commentary — what changed since Everything below is what sits behind that. I want to check my reasoning rather…
|
+15 | 19 | 12k | 13h |
|
GIP receptor agonism and the argument about direction
GIP receptor agonism and the argument about direction — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will otherwise…
|
2 | 867 | 10mo | |
|
Revisiting: Five questions in one post gets you one answer — how to split them
Revisiting: Five questions in one post gets you one answer — how to split them Writing it up because I had to work it out twice and would rather nobody else did. Question in the title. Context below, and I…
|
+2 | 6 | 13k | 20mo |
|
Tracking semaglutide's approved indications across jurisdictions, dated
Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited…
|
+15 | 19 | 2.8k | 1d |